nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2C9—brain cancer	0.497	1	CbGaD
Cyclophosphamide—CYP2D6—Lomustine—brain cancer	0.0541	0.231	CbGbCtD
Cyclophosphamide—CYP2D6—Hydroxyurea—brain cancer	0.041	0.175	CbGbCtD
Cyclophosphamide—CYP3A4—Temozolomide—brain cancer	0.0405	0.173	CbGbCtD
Cyclophosphamide—CYP3A4—Lomustine—brain cancer	0.0344	0.147	CbGbCtD
Cyclophosphamide—CYP3A5—Etoposide—brain cancer	0.0213	0.0911	CbGbCtD
Cyclophosphamide—CYP2C8—Etoposide—brain cancer	0.0205	0.0876	CbGbCtD
Cyclophosphamide—ABCB1—Etoposide—brain cancer	0.0139	0.0593	CbGbCtD
Cyclophosphamide—CYP3A4—Etoposide—brain cancer	0.00831	0.0355	CbGbCtD
Cyclophosphamide—Ifosfamide—CYP2C9—brain cancer	0.00363	1	CrCbGaD
Cyclophosphamide—CYP2C18—Xenobiotics—CYP2C9—brain cancer	0.00163	0.0377	CbGpPWpGaD
Cyclophosphamide—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.0016	0.0371	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00157	0.0363	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00141	0.0327	CbGpPWpGaD
Cyclophosphamide—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00129	0.0299	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00128	0.0297	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00126	0.0292	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00114	0.0265	CbGpPWpGaD
Cyclophosphamide—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00109	0.0253	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.00108	0.0251	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.000991	0.023	CbGpPWpGaD
Cyclophosphamide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000975	0.0226	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000953	0.0221	CbGpPWpGaD
Cyclophosphamide—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000897	0.0208	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.0008	0.0185	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000782	0.0181	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000752	0.0174	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000681	0.0158	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000677	0.0157	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000675	0.0157	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000667	0.0155	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000651	0.0151	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000604	0.014	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000581	0.0135	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000556	0.0129	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000549	0.0127	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000548	0.0127	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000537	0.0124	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000535	0.0124	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000523	0.0121	CbGpPWpGaD
Cyclophosphamide—CYP2C18—FOXA1 transcription factor network—SHH—brain cancer	0.0005	0.0116	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000449	0.0104	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000443	0.0103	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000415	0.00962	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000412	0.00954	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000406	0.00942	CbGpPWpGaD
Cyclophosphamide—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000405	0.00939	CbGpPWpGaD
Cyclophosphamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000386	0.00894	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000364	0.00844	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000363	0.00842	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00035	0.0081	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000334	0.00773	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000332	0.0077	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000328	0.0076	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000325	0.00754	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000325	0.00752	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00032	0.00743	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Biological oxidations—CYP2C9—brain cancer	0.000291	0.00674	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00029	0.00673	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metapathway biotransformation—CYP2C9—brain cancer	0.000287	0.00665	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000281	0.00652	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000277	0.00643	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000276	0.00639	CbGpPWpGaD
Cyclophosphamide—Hyponatraemia—Carmustine—brain cancer	0.000272	0.00122	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00027	0.00122	CcSEcCtD
Cyclophosphamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000269	0.00624	CbGpPWpGaD
Cyclophosphamide—Chills—Procarbazine—brain cancer	0.000268	0.00121	CcSEcCtD
Cyclophosphamide—Arrhythmia—Procarbazine—brain cancer	0.000267	0.0012	CcSEcCtD
Cyclophosphamide—Body temperature increased—Lomustine—brain cancer	0.000265	0.00119	CcSEcCtD
Cyclophosphamide—Alopecia—Procarbazine—brain cancer	0.000264	0.00119	CcSEcCtD
Cyclophosphamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000263	0.0061	CbGpPWpGaD
Cyclophosphamide—Weight increased—Hydroxyurea—brain cancer	0.000263	0.00119	CcSEcCtD
Cyclophosphamide—Mouth ulceration—Etoposide—brain cancer	0.00026	0.00117	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000253	0.00114	CcSEcCtD
Cyclophosphamide—Stomatitis—Hydroxyurea—brain cancer	0.000251	0.00113	CcSEcCtD
Cyclophosphamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000251	0.00582	CbGpPWpGaD
Cyclophosphamide—Sepsis—Etoposide—brain cancer	0.00025	0.00113	CcSEcCtD
Cyclophosphamide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00025	0.00578	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000248	0.00574	CbGpPWpGaD
Cyclophosphamide—Tremor—Procarbazine—brain cancer	0.000244	0.0011	CcSEcCtD
Cyclophosphamide—Phlebitis—Etoposide—brain cancer	0.000243	0.00109	CcSEcCtD
Cyclophosphamide—Anaemia—Procarbazine—brain cancer	0.000241	0.00108	CcSEcCtD
Cyclophosphamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000238	0.00551	CbGpPWpGaD
Cyclophosphamide—Swelling—Etoposide—brain cancer	0.000237	0.00107	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000235	0.00106	CcSEcCtD
Cyclophosphamide—Leukopenia—Procarbazine—brain cancer	0.000233	0.00105	CcSEcCtD
Cyclophosphamide—Haemoglobin—Hydroxyurea—brain cancer	0.000233	0.00105	CcSEcCtD
Cyclophosphamide—Haemorrhage—Hydroxyurea—brain cancer	0.000231	0.00104	CcSEcCtD
Cyclophosphamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000231	0.00535	CbGpPWpGaD
Cyclophosphamide—Cardiac failure congestive—Etoposide—brain cancer	0.000231	0.00104	CcSEcCtD
Cyclophosphamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000228	0.00528	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000228	0.00528	CbGpPWpGaD
Cyclophosphamide—Cough—Procarbazine—brain cancer	0.000227	0.00102	CcSEcCtD
Cyclophosphamide—Convulsion—Procarbazine—brain cancer	0.000226	0.00102	CcSEcCtD
Cyclophosphamide—Hypertension—Procarbazine—brain cancer	0.000225	0.00101	CcSEcCtD
Cyclophosphamide—Pancytopenia—Carmustine—brain cancer	0.000222	0.001	CcSEcCtD
Cyclophosphamide—Arthralgia—Procarbazine—brain cancer	0.000222	0.000999	CcSEcCtD
Cyclophosphamide—Myalgia—Procarbazine—brain cancer	0.000222	0.000999	CcSEcCtD
Cyclophosphamide—Sweating increased—Temozolomide—brain cancer	0.00022	0.000992	CcSEcCtD
Cyclophosphamide—Pancytopenia—Temozolomide—brain cancer	0.000215	0.000967	CcSEcCtD
Cyclophosphamide—Cardiac failure—Etoposide—brain cancer	0.000214	0.000966	CcSEcCtD
Cyclophosphamide—Confusional state—Procarbazine—brain cancer	0.000214	0.000966	CcSEcCtD
Cyclophosphamide—Vomiting—Lomustine—brain cancer	0.000213	0.000959	CcSEcCtD
Cyclophosphamide—Oedema—Procarbazine—brain cancer	0.000212	0.000958	CcSEcCtD
Cyclophosphamide—Infection—Procarbazine—brain cancer	0.000211	0.000952	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Carmustine—brain cancer	0.000211	0.000951	CcSEcCtD
Cyclophosphamide—Pneumonia—Carmustine—brain cancer	0.00021	0.000945	CcSEcCtD
Cyclophosphamide—Shock—Procarbazine—brain cancer	0.000209	0.000943	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Procarbazine—brain cancer	0.000208	0.000938	CcSEcCtD
Cyclophosphamide—Chills—Hydroxyurea—brain cancer	0.000208	0.000936	CcSEcCtD
Cyclophosphamide—Tachycardia—Procarbazine—brain cancer	0.000207	0.000935	CcSEcCtD
Cyclophosphamide—Weight increased—Temozolomide—brain cancer	0.000206	0.000927	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Procarbazine—brain cancer	0.000205	0.000926	CcSEcCtD
Cyclophosphamide—Renal failure—Carmustine—brain cancer	0.000205	0.000924	CcSEcCtD
Cyclophosphamide—Alopecia—Hydroxyurea—brain cancer	0.000204	0.000922	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Carmustine—brain cancer	0.000204	0.000921	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Temozolomide—brain cancer	0.000204	0.000919	CcSEcCtD
Cyclophosphamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000203	0.00472	CbGpPWpGaD
Cyclophosphamide—Stomatitis—Carmustine—brain cancer	0.000203	0.000916	CcSEcCtD
Cyclophosphamide—Pneumonia—Temozolomide—brain cancer	0.000203	0.000913	CcSEcCtD
Cyclophosphamide—Anorexia—Procarbazine—brain cancer	0.000203	0.000913	CcSEcCtD
Cyclophosphamide—Erythema—Hydroxyurea—brain cancer	0.000201	0.000908	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.0002	0.0009	CcSEcCtD
Cyclophosphamide—Cardiac arrest—Etoposide—brain cancer	0.000199	0.000897	CcSEcCtD
Cyclophosphamide—Nausea—Lomustine—brain cancer	0.000199	0.000896	CcSEcCtD
Cyclophosphamide—Hypotension—Procarbazine—brain cancer	0.000199	0.000895	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Temozolomide—brain cancer	0.000197	0.00089	CcSEcCtD
Cyclophosphamide—Stomatitis—Temozolomide—brain cancer	0.000196	0.000885	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000194	0.000873	CcSEcCtD
Cyclophosphamide—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000193	0.00448	CbGpPWpGaD
Cyclophosphamide—Paraesthesia—Procarbazine—brain cancer	0.000191	0.00086	CcSEcCtD
Cyclophosphamide—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000191	0.00442	CbGpPWpGaD
Cyclophosphamide—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000188	0.000849	CcSEcCtD
Cyclophosphamide—Haemoglobin—Carmustine—brain cancer	0.000188	0.000848	CcSEcCtD
Cyclophosphamide—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000188	0.00436	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000187	0.00434	CbGpPWpGaD
Cyclophosphamide—Haemorrhage—Carmustine—brain cancer	0.000187	0.000844	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Hydroxyurea—brain cancer	0.000187	0.000843	CcSEcCtD
Cyclophosphamide—Anaemia—Hydroxyurea—brain cancer	0.000186	0.00084	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Carmustine—brain cancer	0.000186	0.000839	CcSEcCtD
Cyclophosphamide—Decreased appetite—Procarbazine—brain cancer	0.000185	0.000833	CcSEcCtD
Cyclophosphamide—Fatigue—Procarbazine—brain cancer	0.000183	0.000826	CcSEcCtD
Cyclophosphamide—Haemoglobin—Temozolomide—brain cancer	0.000182	0.000819	CcSEcCtD
Cyclophosphamide—Malaise—Hydroxyurea—brain cancer	0.000182	0.000819	CcSEcCtD
Cyclophosphamide—Pain—Procarbazine—brain cancer	0.000182	0.000819	CcSEcCtD
Cyclophosphamide—Constipation—Procarbazine—brain cancer	0.000182	0.000819	CcSEcCtD
Cyclophosphamide—Hepatitis—Temozolomide—brain cancer	0.000181	0.000815	CcSEcCtD
Cyclophosphamide—Haemorrhage—Temozolomide—brain cancer	0.000181	0.000815	CcSEcCtD
Cyclophosphamide—Leukopenia—Hydroxyurea—brain cancer	0.00018	0.000813	CcSEcCtD
Cyclophosphamide—Visual impairment—Carmustine—brain cancer	0.00018	0.000813	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Temozolomide—brain cancer	0.00018	0.000811	CcSEcCtD
Cyclophosphamide—Bronchospasm—Etoposide—brain cancer	0.000178	0.000802	CcSEcCtD
Cyclophosphamide—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000177	0.00411	CbGpPWpGaD
Cyclophosphamide—Sweating increased—Etoposide—brain cancer	0.000176	0.000794	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Procarbazine—brain cancer	0.000175	0.000789	CcSEcCtD
Cyclophosphamide—Convulsion—Hydroxyurea—brain cancer	0.000175	0.000787	CcSEcCtD
Cyclophosphamide—Visual impairment—Temozolomide—brain cancer	0.000174	0.000786	CcSEcCtD
Cyclophosphamide—Flushing—Carmustine—brain cancer	0.000174	0.000783	CcSEcCtD
Cyclophosphamide—Pancytopenia—Etoposide—brain cancer	0.000172	0.000774	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Temozolomide—brain cancer	0.000171	0.000771	CcSEcCtD
Cyclophosphamide—Discomfort—Hydroxyurea—brain cancer	0.000169	0.000764	CcSEcCtD
Cyclophosphamide—Urticaria—Procarbazine—brain cancer	0.000169	0.000761	CcSEcCtD
Cyclophosphamide—Tinnitus—Temozolomide—brain cancer	0.000169	0.00076	CcSEcCtD
Cyclophosphamide—Body temperature increased—Procarbazine—brain cancer	0.000168	0.000757	CcSEcCtD
Cyclophosphamide—Flushing—Temozolomide—brain cancer	0.000168	0.000757	CcSEcCtD
Cyclophosphamide—Arrhythmia—Carmustine—brain cancer	0.000167	0.000754	CcSEcCtD
Cyclophosphamide—Alopecia—Carmustine—brain cancer	0.000165	0.000745	CcSEcCtD
Cyclophosphamide—Oedema—Hydroxyurea—brain cancer	0.000164	0.000741	CcSEcCtD
Cyclophosphamide—Infection—Hydroxyurea—brain cancer	0.000163	0.000737	CcSEcCtD
Cyclophosphamide—Erythema—Carmustine—brain cancer	0.000163	0.000734	CcSEcCtD
Cyclophosphamide—Chills—Temozolomide—brain cancer	0.000162	0.000732	CcSEcCtD
Cyclophosphamide—Pneumonia—Etoposide—brain cancer	0.000162	0.000731	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000161	0.000726	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00016	0.00072	CcSEcCtD
Cyclophosphamide—Alopecia—Temozolomide—brain cancer	0.00016	0.00072	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Etoposide—brain cancer	0.000159	0.000716	CcSEcCtD
Cyclophosphamide—Renal failure—Etoposide—brain cancer	0.000158	0.000714	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Etoposide—brain cancer	0.000158	0.000712	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Etoposide—brain cancer	0.000158	0.000712	CcSEcCtD
Cyclophosphamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000158	0.00366	CbGpPWpGaD
Cyclophosphamide—Erythema—Temozolomide—brain cancer	0.000157	0.00071	CcSEcCtD
Cyclophosphamide—Stomatitis—Etoposide—brain cancer	0.000157	0.000708	CcSEcCtD
Cyclophosphamide—Jaundice—Etoposide—brain cancer	0.000157	0.000708	CcSEcCtD
Cyclophosphamide—Anorexia—Hydroxyurea—brain cancer	0.000157	0.000707	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Procarbazine—brain cancer	0.000157	0.000706	CcSEcCtD
Cyclophosphamide—Dysgeusia—Temozolomide—brain cancer	0.000154	0.000695	CcSEcCtD
Cyclophosphamide—Vision blurred—Carmustine—brain cancer	0.000153	0.000692	CcSEcCtD
Cyclophosphamide—Tremor—Carmustine—brain cancer	0.000153	0.000688	CcSEcCtD
Cyclophosphamide—Asthenia—Procarbazine—brain cancer	0.000152	0.000687	CcSEcCtD
Cyclophosphamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000151	0.0035	CbGpPWpGaD
Cyclophosphamide—Anaemia—Carmustine—brain cancer	0.000151	0.000679	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Etoposide—brain cancer	0.00015	0.000678	CcSEcCtD
Cyclophosphamide—Pruritus—Procarbazine—brain cancer	0.00015	0.000678	CcSEcCtD
Cyclophosphamide—Agitation—Carmustine—brain cancer	0.00015	0.000675	CcSEcCtD
Cyclophosphamide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000149	0.00345	CbGpPWpGaD
Cyclophosphamide—Vision blurred—Temozolomide—brain cancer	0.000148	0.000669	CcSEcCtD
Cyclophosphamide—Tremor—Temozolomide—brain cancer	0.000147	0.000665	CcSEcCtD
Cyclophosphamide—Dyspnoea—Hydroxyurea—brain cancer	0.000147	0.000661	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Temozolomide—brain cancer	0.000146	0.000658	CcSEcCtD
Cyclophosphamide—Leukopenia—Carmustine—brain cancer	0.000146	0.000657	CcSEcCtD
Cyclophosphamide—Anaemia—Temozolomide—brain cancer	0.000145	0.000656	CcSEcCtD
Cyclophosphamide—Diarrhoea—Procarbazine—brain cancer	0.000145	0.000655	CcSEcCtD
Cyclophosphamide—Agitation—Temozolomide—brain cancer	0.000145	0.000652	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Etoposide—brain cancer	0.000144	0.000649	CcSEcCtD
Cyclophosphamide—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000143	0.00331	CbGpPWpGaD
Cyclophosphamide—Decreased appetite—Hydroxyurea—brain cancer	0.000143	0.000645	CcSEcCtD
Cyclophosphamide—Malaise—Temozolomide—brain cancer	0.000142	0.00064	CcSEcCtD
Cyclophosphamide—Fatigue—Hydroxyurea—brain cancer	0.000142	0.000639	CcSEcCtD
Cyclophosphamide—Convulsion—Carmustine—brain cancer	0.000141	0.000636	CcSEcCtD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000141	0.00327	CbGpPWpGaD
Cyclophosphamide—Leukopenia—Temozolomide—brain cancer	0.000141	0.000635	CcSEcCtD
Cyclophosphamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000141	0.00326	CbGpPWpGaD
Cyclophosphamide—Hypertension—Carmustine—brain cancer	0.000141	0.000634	CcSEcCtD
Cyclophosphamide—Constipation—Hydroxyurea—brain cancer	0.000141	0.000634	CcSEcCtD
Cyclophosphamide—Pain—Hydroxyurea—brain cancer	0.000141	0.000634	CcSEcCtD
Cyclophosphamide—Dizziness—Procarbazine—brain cancer	0.00014	0.000634	CcSEcCtD
Cyclophosphamide—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.00014	0.00324	CbGpPWpGaD
Cyclophosphamide—Palpitations—Temozolomide—brain cancer	0.000139	0.000627	CcSEcCtD
Cyclophosphamide—Chest pain—Carmustine—brain cancer	0.000139	0.000625	CcSEcCtD
Cyclophosphamide—Myalgia—Carmustine—brain cancer	0.000139	0.000625	CcSEcCtD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000138	0.0032	CbGpPWpGaD
Cyclophosphamide—Cough—Temozolomide—brain cancer	0.000137	0.000619	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Etoposide—brain cancer	0.000137	0.000617	CcSEcCtD
Cyclophosphamide—Convulsion—Temozolomide—brain cancer	0.000136	0.000615	CcSEcCtD
Cyclophosphamide—Hypertension—Temozolomide—brain cancer	0.000136	0.000613	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Hydroxyurea—brain cancer	0.000135	0.000611	CcSEcCtD
Cyclophosphamide—Vomiting—Procarbazine—brain cancer	0.000135	0.000609	CcSEcCtD
Cyclophosphamide—Flushing—Etoposide—brain cancer	0.000134	0.000605	CcSEcCtD
Cyclophosphamide—Confusional state—Carmustine—brain cancer	0.000134	0.000604	CcSEcCtD
Cyclophosphamide—Arthralgia—Temozolomide—brain cancer	0.000134	0.000604	CcSEcCtD
Cyclophosphamide—Myalgia—Temozolomide—brain cancer	0.000134	0.000604	CcSEcCtD
Cyclophosphamide—Rash—Procarbazine—brain cancer	0.000134	0.000604	CcSEcCtD
Cyclophosphamide—Dermatitis—Procarbazine—brain cancer	0.000134	0.000603	CcSEcCtD
Cyclophosphamide—Headache—Procarbazine—brain cancer	0.000133	0.0006	CcSEcCtD
Cyclophosphamide—Oedema—Carmustine—brain cancer	0.000133	0.000599	CcSEcCtD
Cyclophosphamide—Discomfort—Temozolomide—brain cancer	0.000132	0.000597	CcSEcCtD
Cyclophosphamide—Infection—Carmustine—brain cancer	0.000132	0.000595	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Carmustine—brain cancer	0.00013	0.000587	CcSEcCtD
Cyclophosphamide—Body temperature increased—Hydroxyurea—brain cancer	0.00013	0.000586	CcSEcCtD
Cyclophosphamide—Chills—Etoposide—brain cancer	0.00013	0.000585	CcSEcCtD
Cyclophosphamide—Tachycardia—Carmustine—brain cancer	0.00013	0.000585	CcSEcCtD
Cyclophosphamide—Confusional state—Temozolomide—brain cancer	0.00013	0.000584	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Temozolomide—brain cancer	0.000128	0.000579	CcSEcCtD
Cyclophosphamide—Oedema—Temozolomide—brain cancer	0.000128	0.000579	CcSEcCtD
Cyclophosphamide—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000128	0.00297	CbGpPWpGaD
Cyclophosphamide—Alopecia—Etoposide—brain cancer	0.000128	0.000576	CcSEcCtD
Cyclophosphamide—Infection—Temozolomide—brain cancer	0.000128	0.000575	CcSEcCtD
Cyclophosphamide—Anorexia—Carmustine—brain cancer	0.000127	0.000571	CcSEcCtD
Cyclophosphamide—Nausea—Procarbazine—brain cancer	0.000126	0.000569	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Temozolomide—brain cancer	0.000126	0.000567	CcSEcCtD
Cyclophosphamide—Hypotension—Carmustine—brain cancer	0.000124	0.00056	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Temozolomide—brain cancer	0.000124	0.00056	CcSEcCtD
Cyclophosphamide—Dysgeusia—Etoposide—brain cancer	0.000123	0.000556	CcSEcCtD
Cyclophosphamide—Anorexia—Temozolomide—brain cancer	0.000122	0.000552	CcSEcCtD
Cyclophosphamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000122	0.00284	CbGpPWpGaD
Cyclophosphamide—Hypersensitivity—Hydroxyurea—brain cancer	0.000121	0.000546	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000121	0.000546	CcSEcCtD
Cyclophosphamide—Muscle spasms—Etoposide—brain cancer	0.000121	0.000546	CcSEcCtD
Cyclophosphamide—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000121	0.00281	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000119	0.00277	CbGpPWpGaD
Cyclophosphamide—Paraesthesia—Carmustine—brain cancer	0.000119	0.000538	CcSEcCtD
Cyclophosphamide—Dyspnoea—Carmustine—brain cancer	0.000118	0.000534	CcSEcCtD
Cyclophosphamide—Asthenia—Hydroxyurea—brain cancer	0.000118	0.000532	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000117	0.000528	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Etoposide—brain cancer	0.000117	0.000527	CcSEcCtD
Cyclophosphamide—Anaemia—Etoposide—brain cancer	0.000116	0.000525	CcSEcCtD
Cyclophosphamide—Decreased appetite—Carmustine—brain cancer	0.000116	0.000521	CcSEcCtD
Cyclophosphamide—Paraesthesia—Temozolomide—brain cancer	0.000115	0.00052	CcSEcCtD
Cyclophosphamide—Dyspnoea—Temozolomide—brain cancer	0.000115	0.000516	CcSEcCtD
Cyclophosphamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000114	0.00263	CbGpPWpGaD
Cyclophosphamide—Pain—Carmustine—brain cancer	0.000114	0.000513	CcSEcCtD
Cyclophosphamide—Constipation—Carmustine—brain cancer	0.000114	0.000513	CcSEcCtD
Cyclophosphamide—Malaise—Etoposide—brain cancer	0.000114	0.000512	CcSEcCtD
Cyclophosphamide—Leukopenia—Etoposide—brain cancer	0.000113	0.000508	CcSEcCtD
Cyclophosphamide—Diarrhoea—Hydroxyurea—brain cancer	0.000112	0.000507	CcSEcCtD
Cyclophosphamide—Decreased appetite—Temozolomide—brain cancer	0.000112	0.000504	CcSEcCtD
Cyclophosphamide—Fatigue—Temozolomide—brain cancer	0.000111	0.000499	CcSEcCtD
Cyclophosphamide—Cough—Etoposide—brain cancer	0.00011	0.000496	CcSEcCtD
Cyclophosphamide—Constipation—Temozolomide—brain cancer	0.00011	0.000495	CcSEcCtD
Cyclophosphamide—Pain—Temozolomide—brain cancer	0.00011	0.000495	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Carmustine—brain cancer	0.00011	0.000494	CcSEcCtD
Cyclophosphamide—Convulsion—Etoposide—brain cancer	0.000109	0.000492	CcSEcCtD
Cyclophosphamide—Hypertension—Etoposide—brain cancer	0.000109	0.00049	CcSEcCtD
Cyclophosphamide—Dizziness—Hydroxyurea—brain cancer	0.000109	0.00049	CcSEcCtD
Cyclophosphamide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000108	0.0025	CbGpPWpGaD
Cyclophosphamide—Chest pain—Etoposide—brain cancer	0.000107	0.000483	CcSEcCtD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000107	0.00247	CbGpPWpGaD
Cyclophosphamide—Discomfort—Etoposide—brain cancer	0.000106	0.000478	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Temozolomide—brain cancer	0.000106	0.000477	CcSEcCtD
Cyclophosphamide—Body temperature increased—Carmustine—brain cancer	0.000105	0.000474	CcSEcCtD
Cyclophosphamide—Vomiting—Hydroxyurea—brain cancer	0.000105	0.000471	CcSEcCtD
Cyclophosphamide—Rash—Hydroxyurea—brain cancer	0.000104	0.000467	CcSEcCtD
Cyclophosphamide—Confusional state—Etoposide—brain cancer	0.000104	0.000467	CcSEcCtD
Cyclophosphamide—Dermatitis—Hydroxyurea—brain cancer	0.000104	0.000467	CcSEcCtD
Cyclophosphamide—Headache—Hydroxyurea—brain cancer	0.000103	0.000464	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Etoposide—brain cancer	0.000103	0.000463	CcSEcCtD
Cyclophosphamide—Infection—Etoposide—brain cancer	0.000102	0.00046	CcSEcCtD
Cyclophosphamide—Urticaria—Temozolomide—brain cancer	0.000102	0.00046	CcSEcCtD
Cyclophosphamide—Body temperature increased—Temozolomide—brain cancer	0.000102	0.000458	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Etoposide—brain cancer	0.000101	0.000454	CcSEcCtD
Cyclophosphamide—Tachycardia—Etoposide—brain cancer	0.0001	0.000452	CcSEcCtD
Cyclophosphamide—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.94e-05	0.0023	CbGpPWpGaD
Cyclophosphamide—Hyperhidrosis—Etoposide—brain cancer	9.94e-05	0.000448	CcSEcCtD
Cyclophosphamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	9.85e-05	0.00228	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	9.8e-05	0.00227	CbGpPWpGaD
Cyclophosphamide—Anorexia—Etoposide—brain cancer	9.8e-05	0.000442	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Carmustine—brain cancer	9.79e-05	0.000442	CcSEcCtD
Cyclophosphamide—Nausea—Hydroxyurea—brain cancer	9.77e-05	0.00044	CcSEcCtD
Cyclophosphamide—Hypotension—Etoposide—brain cancer	9.6e-05	0.000433	CcSEcCtD
Cyclophosphamide—Asthenia—Carmustine—brain cancer	9.54e-05	0.00043	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Temozolomide—brain cancer	9.46e-05	0.000427	CcSEcCtD
Cyclophosphamide—Paraesthesia—Etoposide—brain cancer	9.23e-05	0.000416	CcSEcCtD
Cyclophosphamide—Asthenia—Temozolomide—brain cancer	9.22e-05	0.000416	CcSEcCtD
Cyclophosphamide—Dyspnoea—Etoposide—brain cancer	9.16e-05	0.000413	CcSEcCtD
Cyclophosphamide—Diarrhoea—Carmustine—brain cancer	9.09e-05	0.00041	CcSEcCtD
Cyclophosphamide—Pruritus—Temozolomide—brain cancer	9.09e-05	0.00041	CcSEcCtD
Cyclophosphamide—Decreased appetite—Etoposide—brain cancer	8.93e-05	0.000403	CcSEcCtD
Cyclophosphamide—Fatigue—Etoposide—brain cancer	8.86e-05	0.0004	CcSEcCtD
Cyclophosphamide—Dizziness—Carmustine—brain cancer	8.79e-05	0.000396	CcSEcCtD
Cyclophosphamide—Constipation—Etoposide—brain cancer	8.79e-05	0.000396	CcSEcCtD
Cyclophosphamide—Pain—Etoposide—brain cancer	8.79e-05	0.000396	CcSEcCtD
Cyclophosphamide—Diarrhoea—Temozolomide—brain cancer	8.79e-05	0.000396	CcSEcCtD
Cyclophosphamide—Dizziness—Temozolomide—brain cancer	8.49e-05	0.000383	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Etoposide—brain cancer	8.47e-05	0.000382	CcSEcCtD
Cyclophosphamide—Vomiting—Carmustine—brain cancer	8.45e-05	0.000381	CcSEcCtD
Cyclophosphamide—Rash—Carmustine—brain cancer	8.38e-05	0.000378	CcSEcCtD
Cyclophosphamide—Dermatitis—Carmustine—brain cancer	8.37e-05	0.000378	CcSEcCtD
Cyclophosphamide—Headache—Carmustine—brain cancer	8.33e-05	0.000375	CcSEcCtD
Cyclophosphamide—Vomiting—Temozolomide—brain cancer	8.17e-05	0.000368	CcSEcCtD
Cyclophosphamide—Urticaria—Etoposide—brain cancer	8.17e-05	0.000368	CcSEcCtD
Cyclophosphamide—Body temperature increased—Etoposide—brain cancer	8.12e-05	0.000366	CcSEcCtD
Cyclophosphamide—Rash—Temozolomide—brain cancer	8.1e-05	0.000365	CcSEcCtD
Cyclophosphamide—Dermatitis—Temozolomide—brain cancer	8.09e-05	0.000365	CcSEcCtD
Cyclophosphamide—Headache—Temozolomide—brain cancer	8.05e-05	0.000363	CcSEcCtD
Cyclophosphamide—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	7.96e-05	0.00184	CbGpPWpGaD
Cyclophosphamide—Nausea—Carmustine—brain cancer	7.89e-05	0.000356	CcSEcCtD
Cyclophosphamide—Nausea—Temozolomide—brain cancer	7.63e-05	0.000344	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Etoposide—brain cancer	7.57e-05	0.000341	CcSEcCtD
Cyclophosphamide—Asthenia—Etoposide—brain cancer	7.37e-05	0.000333	CcSEcCtD
Cyclophosphamide—Pruritus—Etoposide—brain cancer	7.27e-05	0.000328	CcSEcCtD
Cyclophosphamide—Diarrhoea—Etoposide—brain cancer	7.03e-05	0.000317	CcSEcCtD
Cyclophosphamide—Dizziness—Etoposide—brain cancer	6.8e-05	0.000306	CcSEcCtD
Cyclophosphamide—ABCB1—Allograft Rejection—PDGFRA—brain cancer	6.72e-05	0.00156	CbGpPWpGaD
Cyclophosphamide—Vomiting—Etoposide—brain cancer	6.53e-05	0.000295	CcSEcCtD
Cyclophosphamide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.5e-05	0.00151	CbGpPWpGaD
Cyclophosphamide—Rash—Etoposide—brain cancer	6.48e-05	0.000292	CcSEcCtD
Cyclophosphamide—Dermatitis—Etoposide—brain cancer	6.47e-05	0.000292	CcSEcCtD
Cyclophosphamide—Headache—Etoposide—brain cancer	6.44e-05	0.00029	CcSEcCtD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.41e-05	0.00149	CbGpPWpGaD
Cyclophosphamide—Nausea—Etoposide—brain cancer	6.11e-05	0.000275	CcSEcCtD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.61e-05	0.0013	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5.31e-05	0.00123	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CYP2C9—brain cancer	4.97e-05	0.00115	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.65e-05	0.00108	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.65e-05	0.00108	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.49e-05	0.00104	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—BSG—brain cancer	4.23e-05	0.00098	CbGpPWpGaD
Cyclophosphamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.2e-05	0.000974	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.15e-05	0.000962	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.68e-05	0.000854	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—IL2—brain cancer	3.67e-05	0.00085	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—IDH1—brain cancer	3.64e-05	0.000843	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.61e-05	0.000837	CbGpPWpGaD
Cyclophosphamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.6e-05	0.000834	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.57e-05	0.000827	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.4e-05	0.000788	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.32e-05	0.000769	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP2C9—brain cancer	3.31e-05	0.000767	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.16e-05	0.000733	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.12e-05	0.000722	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.03e-05	0.000703	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP2C9—brain cancer	3.03e-05	0.000703	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—ENO2—brain cancer	2.87e-05	0.000666	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—BSG—brain cancer	2.81e-05	0.000652	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.77e-05	0.000641	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.73e-05	0.000633	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—BSG—brain cancer	2.58e-05	0.000597	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.57e-05	0.000596	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP2C9—brain cancer	2.45e-05	0.000567	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—IDH1—brain cancer	2.42e-05	0.00056	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP2C9—brain cancer	2.39e-05	0.000554	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—IDH1—brain cancer	2.22e-05	0.000514	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.15e-05	0.000498	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—BSG—brain cancer	2.08e-05	0.000482	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP2C9—brain cancer	2.07e-05	0.00048	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—BSG—brain cancer	2.03e-05	0.000471	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2e-05	0.000463	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ENO2—brain cancer	1.91e-05	0.000443	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP2C9—brain cancer	1.85e-05	0.000428	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP2C9—brain cancer	1.8e-05	0.000418	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—IDH1—brain cancer	1.79e-05	0.000414	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.76e-05	0.000409	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—BSG—brain cancer	1.76e-05	0.000408	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ENO2—brain cancer	1.75e-05	0.000406	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—IDH1—brain cancer	1.75e-05	0.000405	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.75e-05	0.000405	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP2C9—brain cancer	1.7e-05	0.000394	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—BSG—brain cancer	1.57e-05	0.000364	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.54e-05	0.000357	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—BSG—brain cancer	1.53e-05	0.000356	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—IDH1—brain cancer	1.51e-05	0.000351	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—BSG—brain cancer	1.45e-05	0.000335	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—BSG—brain cancer	1.43e-05	0.000332	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.42e-05	0.000328	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ENO2—brain cancer	1.41e-05	0.000328	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.38e-05	0.000321	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ENO2—brain cancer	1.38e-05	0.00032	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—IDH1—brain cancer	1.35e-05	0.000313	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—IDH1—brain cancer	1.32e-05	0.000306	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CG—brain cancer	1.32e-05	0.000306	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—IDH1—brain cancer	1.24e-05	0.000288	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.23e-05	0.000286	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—IDH1—brain cancer	1.23e-05	0.000286	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ENO2—brain cancer	1.2e-05	0.000277	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.16e-05	0.000269	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2C9—brain cancer	1.11e-05	0.000258	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.1e-05	0.000255	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ENO2—brain cancer	1.07e-05	0.000248	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ENO2—brain cancer	1.04e-05	0.000242	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1e-05	0.000233	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ENO2—brain cancer	9.82e-06	0.000228	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ENO2—brain cancer	9.74e-06	0.000226	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—BSG—brain cancer	9.45e-06	0.000219	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CG—brain cancer	8.77e-06	0.000203	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—IDH1—brain cancer	8.13e-06	0.000188	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CG—brain cancer	8.04e-06	0.000186	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CG—brain cancer	6.48e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ENO2—brain cancer	6.42e-06	0.000149	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CG—brain cancer	6.34e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CG—brain cancer	5.49e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CG—brain cancer	4.9e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CG—brain cancer	4.78e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CG—brain cancer	4.51e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CG—brain cancer	4.47e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CG—brain cancer	2.95e-06	6.83e-05	CbGpPWpGaD
